The D614G Mutation Enhances the Lysosomal Trafficking of SARS-CoV-2 Spike
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
The spike D614G mutation increases SARS-CoV-2 infectivity, viral load, and transmission but the molecular mechanism underlying these effects remains unclear. We report here that spike is trafficked to lysosomes and that the D614G mutation enhances the lysosomal sorting of spike and the lysosomal accumulation of spike-positive punctae in SARS-CoV-2-infected cells. Spike trafficking to lysosomes is an endocytosis-independent, V-ATPase-dependent process, and spike-containing lysosomes drive lysosome clustering but display poor lysotracker labeling and reduced uptake of endocytosed materials. These results are consistent with a lysosomal pathway of coronavirus biogenesis and raise the possibility that a common mechanism may underly the D614G mutation’s effects on spike protein trafficking in infected cells and the accelerated entry of SARS-CoV-2 into uninfected cells.
Article activity feed
-
SciScore for 10.1101/2020.12.08.417022: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Following Johns Hopkins Medicine Institutional Review Board (IRB) approval, plasma samples were obtained under informed consent from healthy donors prior to the COVID-19 pandemic (JHM IRB NA_0004638) as described (Cox et al., 2005).
Consent: Following Johns Hopkins Medicine Institutional Review Board (IRB) approval, plasma samples were obtained under informed consent from healthy donors prior to the COVID-19 pandemic (JHM IRB NA_0004638) as described (Cox et al., 2005).Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Reso… SciScore for 10.1101/2020.12.08.417022: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Following Johns Hopkins Medicine Institutional Review Board (IRB) approval, plasma samples were obtained under informed consent from healthy donors prior to the COVID-19 pandemic (JHM IRB NA_0004638) as described (Cox et al., 2005).
Consent: Following Johns Hopkins Medicine Institutional Review Board (IRB) approval, plasma samples were obtained under informed consent from healthy donors prior to the COVID-19 pandemic (JHM IRB NA_0004638) as described (Cox et al., 2005).Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources ThermoFisher was the source for rabbit antibodies directed against LAMTOR1 (#8975S), ERGIC3 (#16029-1-AP), ERGIC53 (#13364-1-AP), and calnexin (#PA5-34665) and for mouse monoclonal antibodies to EEA1 (#48453) and Lamp2 (MA1-205). LAMTOR1suggested: NoneERGIC3suggested: (Proteintech Cat# 16029-1-AP, RRID:AB_2098446)#16029-1-APsuggested: (Proteintech Cat# 16029-1-AP, RRID:AB_2098446)ERGIC53suggested: None#13364-1-APsuggested: (Proteintech Cat# 13364-1-AP, RRID:AB_2135994)calnexin ( #PA5-34665 )suggested: NoneEEA1suggested: NoneLamp2suggested: (Thermo Fisher Scientific Cat# MA1-205, RRID:AB_2662613)Rabbit antibodies to mTOR were obtained from Cell Signaling (#2972S) mTORsuggested: (Cell Signaling Technology Cat# 2972, RRID:AB_330978)Mouse monoclonal antibodies to GM130 (#610822) and CD81 (#555675) were obtained from BD. GM130suggested: (BD Biosciences Cat# 610822, RRID:AB_398141)CD81suggested: (BD Biosciences Cat# 555675, RRID:AB_396028)Mouse monoclonal antibody directed against CD9 (#312102) was obtained from BioLegend. CD9suggested: (BioLegend Cat# 312102, RRID:AB_314907)Fluorescently labeled secondary antibodies specific for human Igs (IgG, IgM, and IgA; pan Ig), human IgG, rabbit IgG, or mouse IgG were obtained from Jackson ImmunoResearch human Igs ( IgGsuggested: Nonehuman IgGsuggested: Nonerabbit IgGsuggested: Nonemouse IgGsuggested: NoneNihal Altan-Bonnet for generous gift of the anti-BiP/GRP78 antibodies, the Lamp1 monoclonal, and polyclonal antibody to the KDEL receptor. anti-BiP/GRP78suggested: NoneLamp1suggested: NoneExperimental Models: Cell Lines Sentences Resources Cell lines, cell culture, transfections: HEK293 cells (ATCC) were cultured in complete medium (DMEM containing 10% fetal bovine serum and 1% penicillin/streptomycin solution (10,000 units/ml)). HEK293suggested: NoneThe clinical isolates SARS-CoV-2/USA/MD-HP00076/2020 (Spike D614; GenBank: MT509475.1) and SARS-Cov-2/USA/DC-HP00007/2020 (Spike G614; GenBank: MT509464.1) were isolated using published procedures (Gniazdowski et al., 2020) and virus stocks were grown on VeroE6TMPRSS2 cells. VeroE6TMPRSS2suggested: JCRB Cat# JCRB1819, RRID:CVCL_YQ49)Software and Algorithms Sentences Resources Images were assembled into figures using Adobe Illustrator. Adobe Illustratorsuggested: (Adobe Illustrator, RRID:SCR_010279)Quantitative analysis of image files was performed using ImageJ and proprietary software. ImageJsuggested: (ImageJ, RRID:SCR_003070)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
